• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Olink蛋白质组学揭示肿瘤坏死因子受体超家族成员9作为腹主动脉瘤的生物标志物。

Olink proteomics reveals TNFRSF9 as a biomarker for abdominal aortic aneurysms.

作者信息

Chang Runze, Wang Heng, Lu Chuanlong, Chen Jinshan, Li Yaling, Qiao Maolin, Gao Siqi, Li Lizheng, Fan Keyi, Zhang Ruijing, Dong Honglin

机构信息

The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Centre for Transplant and Renal Research, Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW 2145, Australia.

出版信息

iScience. 2025 Jun 5;28(7):112828. doi: 10.1016/j.isci.2025.112828. eCollection 2025 Jul 18.

DOI:10.1016/j.isci.2025.112828
PMID:40599317
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12209979/
Abstract

Abdominal aortic aneurysm (AAA) is a serious cardiovascular disease associated with chronic inflammation. The purpose of this study was to use the Olink proteomics to reveal serum inflammatory markers in AAA. We examined the expression levels of 92 inflammation-related proteins in patients with AAA ( = 18) and healthy individuals ( = 10) using the Olink proximity extension assay (PEA) inflammatory plate. Olink proteomics identified 38 differential proteins. Combined analysis of Olink proteomics and GSE183464 showed interleukin-6 (IL-6) and tumor necrosis factor receptor superfamily member 9 (TNFRSF9) were upregulated at both gene and protein levels in AAA patients. The ELISA results were consistent with the Olink proteomics results, and the receiver operating characteristic (ROC) curve analysis revealed that the binding of TNFRSF9 and IL-6 has high diagnostic value (Olink AUC = 0.9056; ELISA AUC = 0.950). Subsequently, elevated TNFRSF9 expression in AAA was confirmed by animal models, suggesting that TNFRSF9 may serve as a potential biomarker for AAA.

摘要

腹主动脉瘤(AAA)是一种与慢性炎症相关的严重心血管疾病。本研究的目的是使用欧林蛋白质组学技术揭示AAA患者血清中的炎症标志物。我们使用欧林邻位延伸分析(PEA)炎症板检测了18例AAA患者和10例健康个体中92种炎症相关蛋白的表达水平。欧林蛋白质组学技术鉴定出38种差异蛋白。欧林蛋白质组学技术与GSE183464的联合分析表明,AAA患者中白细胞介素-6(IL-6)和肿瘤坏死因子受体超家族成员9(TNFRSF9)在基因和蛋白水平均上调。酶联免疫吸附测定(ELISA)结果与欧林蛋白质组学技术结果一致,受试者工作特征(ROC)曲线分析显示,TNFRSF9与IL-6的结合具有较高的诊断价值(欧林蛋白质组学技术曲线下面积[AUC]=0.9056;ELISA AUC=0.950)。随后,动物模型证实了AAA中TNFRSF9表达升高,这表明TNFRSF9可能是AAA的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d31/12209979/74ac8175f262/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d31/12209979/dad79f9a6ba4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d31/12209979/62a614ee4c72/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d31/12209979/74ac8175f262/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d31/12209979/dad79f9a6ba4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d31/12209979/62a614ee4c72/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d31/12209979/74ac8175f262/gr2.jpg

相似文献

1
Olink proteomics reveals TNFRSF9 as a biomarker for abdominal aortic aneurysms.Olink蛋白质组学揭示肿瘤坏死因子受体超家族成员9作为腹主动脉瘤的生物标志物。
iScience. 2025 Jun 5;28(7):112828. doi: 10.1016/j.isci.2025.112828. eCollection 2025 Jul 18.
2
Laparoscopic surgery for elective abdominal aortic aneurysm repair.择期腹主动脉瘤修复的腹腔镜手术
Cochrane Database Syst Rev. 2017 May 4;5(5):CD012302. doi: 10.1002/14651858.CD012302.pub2.
3
Medical treatment for small abdominal aortic aneurysms.小腹主动脉瘤的医学治疗。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009536. doi: 10.1002/14651858.CD009536.pub2.
4
Endovascular treatment for ruptured abdominal aortic aneurysm.破裂性腹主动脉瘤的血管内治疗
Cochrane Database Syst Rev. 2017 May 26;5(5):CD005261. doi: 10.1002/14651858.CD005261.pub4.
5
Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm.通过药物治疗血管危险因素以降低腹主动脉瘤患者的死亡率和心血管事件发生率。
Cochrane Database Syst Rev. 2017 Jan 12;1(1):CD010447. doi: 10.1002/14651858.CD010447.pub3.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Exploring circulating cell-free DNA as a biomarker and as an inducer of AIM2-inflammasome-mediated inflammation in patients with abdominal aortic aneurysm.探索循环游离DNA作为腹主动脉瘤患者生物标志物以及AIM2炎性小体介导炎症诱导物的作用。
Sci Rep. 2025 Jun 20;15(1):20196. doi: 10.1038/s41598-025-06220-5.
8
Deciphering the transcriptomic characteristic of lactate metabolism and the immune infiltration landscape in abdominal aortic aneurysm.解析腹主动脉瘤中乳酸代谢的转录组特征及免疫浸润格局。
Biochem Biophys Res Commun. 2025 Jun 14;776:152198. doi: 10.1016/j.bbrc.2025.152198.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.

本文引用的文献

1
Circulating monocyte populations as biomarker for abdominal aortic aneurysms: a single-center retrospective cohort study.循环单核细胞群体作为腹主动脉瘤的生物标志物:一项单中心回顾性队列研究。
Front Immunol. 2024 Jul 30;15:1418625. doi: 10.3389/fimmu.2024.1418625. eCollection 2024.
2
Causal role of circulating inflammatory cytokines in cardiac diseases, structure and function.循环炎症细胞因子在心脏疾病结构和功能中的因果作用。
Heart Lung. 2024 Sep-Oct;67:70-79. doi: 10.1016/j.hrtlng.2024.04.018. Epub 2024 May 7.
3
Protective Effect of CD137 Deficiency Against Postinfarction Cardiac Fibrosis and Adverse Cardiac Remodeling by ERK1/2 Signaling Pathways.
CD137 缺乏通过 ERK1/2 信号通路对心肌梗死后心脏纤维化和不良心脏重构的保护作用。
J Cardiovasc Pharmacol. 2024 May 1;83(5):446-456. doi: 10.1097/FJC.0000000000001549.
4
Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms.编辑推荐——欧洲血管外科学会(ESVS)2024年腹主动脉-髂动脉瘤管理临床实践指南
Eur J Vasc Endovasc Surg. 2024 Feb;67(2):192-331. doi: 10.1016/j.ejvs.2023.11.002. Epub 2024 Jan 23.
5
Macrophage-derived GSDMD promotes abdominal aortic aneurysm and aortic smooth muscle cells pyroptosis.巨噬细胞衍生的GSDMD促进腹主动脉瘤和主动脉平滑肌细胞焦亡。
Int Immunopharmacol. 2024 Feb 15;128:111554. doi: 10.1016/j.intimp.2024.111554. Epub 2024 Jan 22.
6
Abdominal aortic aneurysms and platelets: infiltration, inflammation, and elastin disintegration.腹主动脉瘤与血小板:浸润、炎症及弹性蛋白分解
Cardiovasc Res. 2024 Mar 30;120(4):331-332. doi: 10.1093/cvr/cvae010.
7
Global research status analysis of the association between aortic aneurysm and inflammation: a bibliometric analysis from 1999 to 2023.主动脉瘤与炎症关联的全球研究现状分析:1999年至2023年的文献计量分析
Front Cardiovasc Med. 2023 Dec 4;10:1260935. doi: 10.3389/fcvm.2023.1260935. eCollection 2023.
8
Involvement of an IgE/Mast cell/B cell amplification loop in abdominal aortic aneurysm progression.IgE/肥大细胞/ B 细胞扩增环在腹主动脉瘤进展中的作用。
PLoS One. 2023 Dec 6;18(12):e0295408. doi: 10.1371/journal.pone.0295408. eCollection 2023.
9
Aortic aneurysms: current pathogenesis and therapeutic targets.主动脉瘤:当前的发病机制和治疗靶点。
Exp Mol Med. 2023 Dec;55(12):2519-2530. doi: 10.1038/s12276-023-01130-w. Epub 2023 Dec 1.
10
Comprehensive bioinformatics analysis revealed potential key genes and pathways underlying abdominal aortic aneurysm.全面的生物信息学分析揭示了腹主动脉瘤潜在的关键基因和通路。
Comput Struct Biotechnol J. 2023 Nov 2;21:5423-5433. doi: 10.1016/j.csbj.2023.10.052. eCollection 2023.